Search
Life Sciences Regulatory Overview In this episode, we explore the complex regulatory landscape of the life sciences industry, providing attorneys with critical insights into the compliance requirements that govern pharmaceuticals, medical devices, and diagnostics. Whether you advise biotech startups...
Life Sciences Industry Basics This episode provides attorneys with a comprehensive foundation in the life sciences industry, equipping legal professionals with the knowledge needed to navigate this complex and highly regulated sector. Whether you advise pharmaceutical companies, biotech startups, or...
Elizabeth Witmer, Chair of Saul Ewing LLP's Energy Practice, will speak at the upcoming Energy Bar Association’s 2024 Mid-Year Energy Forum in a program titled “Recent Developments at the D.C. Circuit Affecting Pipeline and LNG Authorization." Elizabeth will be on a panel with two other attorneys...
Understanding the complex intersection of environmental regulations intended to combat climate change between now and 2050 while responding to the U.S. tech economy’s exponential growth in energy demand will require collaboration between consumers, industry and government, and reliance upon a...
The law firm of Saul Ewing and their sponsors, Langan Engineering & Environmental Services and Spirit Environmental, hosted their 8th Biennial Energy and the Environment Symposium in Houston, Texas. This complimentary half-day hybrid MCLE brought together in-house counsel, prominent industry...
PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...
Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...